FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W370892512> ?p ?o ?g. }

• W370892512 abstract "The synthesis of a series of N-9-fluorenylmethoxycarbonyl (N-FMOC) protected amino acid glycosides is reported. These (1-2)-trans glycosides came directly from Koenigs-Knorr type glycosylations under Hanessian's silver triflate conditions, except for the synthesis of N-acetylgalactosamine FMOC amino acid in which silver perchlorate conditions were used to promote α-glycoside formation. The effect of D-amino acid aglycones was investigated under glucosylation conditions, and a yield dependence on amino protection was seen in the enantiomers of threonine. Due to this match vs. mismatch dichotomy, both O'Donnell Schiff bases and FMOC-amino aglycones were used in the subsequent glycosylation reactions. Glycosides were made using the monosaccharides xylose, mannose, glucose, galactose, N-acetylglucosamine, N-acetylgalactosamine, and disaccharides lactose [galactose-β-(1-4)-glucose], cellobiose [glucose-β-(1-4)-glucose] and melibiose [galactose-α-(1-6)-glucose]. All glycosides were converted to their respective FMOC-amino acid forms for direct use in solid-phase glycopeptide synthesis (SPGPS) using established methodology. A strategy into the synthesis of an FMOC-amino acid trisaccharide of Lewis ˣ (Leˣ) was also investigated in an effort to expand on the established glycoside methodology. Preliminary work with D-glucosamine and L-fucose is reported. Our synthetic rationale was based on retaining the peptide pharmacophore or message sequence constant as DCDCE (D-cys²ʼ⁵-enkephalin) with a serine-glycine tether, and making changes only in the environment of the amino-acid glycoside. Changes in amino acid, amino acid chirality, and in the sugar moiety itself would provide a stereochemical investigation into the requisite orientation and electronics for optimum blood-brain barrier (BBB) penetration, opiate receptor binding, and analgesia. Several glycopeptides were synthesized, and all were purified in both reduced and oxidized forms (if containing cysteine). A highly optimized glycopeptide synthetic strategy has been developed and will be presented and critiqued. Pharmacological analysis involving serum stability studies, BBB-penetration studies, GPI/MVD physicochemical studies and mu/delta-opiate receptor studies were completed on all glycopeptides. SAM-1095, the most potent of the glycopeptides synthesized, was resynthesized on a large scale, and this compound was assessed for in vivo pharmacology, along with the non-glycosylated version SAM-995. Preliminary results demonstrate an analgesic effect similar to that of the narcotic morphine. Assessment of all pharmacology will afford a platform for future SAR-based glycopeptide investigations." @default.
• W370892512 created "2016-06-24" @default.
• W370892512 creator A5062561155 @default.
• W370892512 date "1999-01-01" @default.
• W370892512 modified "2023-09-28" @default.
• W370892512 title "O-glycopeptide analogues of enkephalin: FMOC-amino acid glycoside synthesis, solid-phase glycopeptide synthesis and optimizations, and pharmacology" @default.
• W370892512 hasPublicationYear "1999" @default.
• W370892512 type Work @default.
• W370892512 sameAs 370892512 @default.
• W370892512 citedByCount "0" @default.
• W370892512 crossrefType "journal-article" @default.
• W370892512 hasAuthorship W370892512A5062561155 @default.
• W370892512 hasConcept C137610392 @default.
• W370892512 hasConcept C185592680 @default.
• W370892512 hasConcept C2780906977 @default.
• W370892512 hasConcept C501593827 @default.
• W370892512 hasConcept C515207424 @default.
• W370892512 hasConcept C55493867 @default.
• W370892512 hasConcept C71240020 @default.
• W370892512 hasConceptScore W370892512C137610392 @default.
• W370892512 hasConceptScore W370892512C185592680 @default.
• W370892512 hasConceptScore W370892512C2780906977 @default.
• W370892512 hasConceptScore W370892512C501593827 @default.
• W370892512 hasConceptScore W370892512C515207424 @default.
• W370892512 hasConceptScore W370892512C55493867 @default.
• W370892512 hasConceptScore W370892512C71240020 @default.
• W370892512 hasLocation W3708925121 @default.
• W370892512 hasOpenAccess W370892512 @default.
• W370892512 hasPrimaryLocation W3708925121 @default.
• W370892512 hasRelatedWork W1850345322 @default.
• W370892512 hasRelatedWork W1966967035 @default.
• W370892512 hasRelatedWork W1981707057 @default.
• W370892512 hasRelatedWork W1999116793 @default.
• W370892512 hasRelatedWork W2003693680 @default.
• W370892512 hasRelatedWork W2003714848 @default.
• W370892512 hasRelatedWork W2022019994 @default.
• W370892512 hasRelatedWork W2058556221 @default.
• W370892512 hasRelatedWork W2077824506 @default.
• W370892512 hasRelatedWork W2085899651 @default.
• W370892512 hasRelatedWork W2089724738 @default.
• W370892512 hasRelatedWork W2108423430 @default.
• W370892512 hasRelatedWork W2389335784 @default.
• W370892512 hasRelatedWork W2410178629 @default.
• W370892512 hasRelatedWork W2949358368 @default.
• W370892512 hasRelatedWork W2949511380 @default.
• W370892512 hasRelatedWork W2949669011 @default.
• W370892512 hasRelatedWork W2951800741 @default.
• W370892512 hasRelatedWork W2951973700 @default.
• W370892512 hasRelatedWork W3027824003 @default.
• W370892512 isParatext "false" @default.
• W370892512 isRetracted "false" @default.
• W370892512 magId "370892512" @default.
• W370892512 workType "article" @default.